Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.
about
Non-alcoholic fatty liver disease: what the clinician needs to know.A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and AdolescenceThe therapy of insulin resistance in other diseases besides type 2 diabetesThe role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic reviewNon-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentTreatment of nonalcoholic steatohepatitis in adults: present and futureNonalcoholic fatty liver disease: new treatmentsHepatic steatosis and Type 2 diabetes: current and future treatment considerations.Metformin and metabolic diseases: a focus on hepatic aspectsSystematic review: Preventive and therapeutic applications of metformin in liver diseaseTreatment of nonalcoholic fatty liver disease: role of AMPK.Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.Practice patterns in NAFLD and NASH: real life differs from published guidelinesNon-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver diseaseInflammatory mediators of hepatic steatosis.Molecular pathways in non-alcoholic fatty liver disease.Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Review article: the management of paediatric nonalcoholic fatty liver disease.Pathogenesis and therapeutic approaches for non-alcoholic fatty liver diseaseA study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease.The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome.The role of metformin in the management of NAFLDEffect of Vitamin E and Metformin on Fatty Liver Disease in Obese Children- Randomized Clinical TrialAn Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical TrialNonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver.KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.Clinical approaches to non-alcoholic fatty liver diseaseManagement of Non-alcoholic Fatty Liver Disease and Steatohepatitis.Current therapeutic strategies in non-alcoholic fatty liver disease.Expert opinion on current therapies for nonalcoholic fatty liver disease.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.
P2860
Q24563068-857AB638-0383-4AD3-B373-471A207CCC63Q26744488-5D8B3392-1C22-4DB9-AB1F-17713CEEDBCEQ26822399-BEA99ED0-9D77-4388-A4CC-924401D566EEQ26825269-97B2E63C-CE2B-41FC-9F09-756BE9D566BAQ26829503-85630822-C453-4567-91A3-7D1B1DD0B695Q26852019-1E735BE8-9AEC-4D8C-A77D-40C530E8A0BCQ26852403-63115573-14E3-4425-8BEC-28E5D2EA366FQ27021161-04BB9E84-6BE8-4C03-B99F-129D60F31B89Q27691399-26843787-5E9F-45B5-B272-376E0A995C40Q28082736-3A6EB947-D3C7-4D26-9D37-B8091784D1A2Q28085535-334D2641-2EC7-49E0-B6DB-17E148E8E901Q30248230-DF6C8FCD-42C5-4BA4-81C6-52B47F7529F9Q30248535-5D4D89DF-D62F-4708-885F-0879BC8B1181Q30277747-8211D4C6-54F2-4D0F-B665-7C7AEDD7F2B5Q30389752-A55A4813-6441-4688-9986-79CB16F5995AQ33563877-09D16803-5E44-4F46-BAD0-2683BD3BD906Q33734136-05ABE2AC-4306-4DDE-A6D7-3F25A98B34B5Q33890230-8AA31852-D3F8-4AFC-A524-6FA0AC4CFC84Q33932461-AD7F7CCC-9ED6-4EB7-BDF5-B5A07F8FEC04Q34412650-4F0D1EC0-AB76-496D-AF20-DED15B6ADB21Q34440962-20AEC5E6-E3B3-4462-AF19-D7B9B2DD1A4EQ34449857-2611F0E0-7B0E-4EAE-8BA9-F83DF65F6AE3Q34921969-7DF8911D-0058-42F2-B2AA-28BD3F7AB279Q35090416-4CE91AEA-B29D-49B7-8BF9-5C8CF4B36473Q35250192-3260DED5-3520-4635-A1E4-C954F8FECBACQ35614956-6F344A01-4328-4722-9CD9-9B208E108E23Q35639142-2B914DED-54F8-4C44-9A17-64F54C818233Q36328050-7EC9966A-D393-4D51-8938-E8A8BE97FEB9Q36470320-66049958-85D3-40DB-B61A-E163E6B3D26AQ36503839-7197E4C1-1CC5-4C45-BB22-7BC90FCF661EQ36791363-A0D74280-A54D-496C-988C-97E483E4365AQ37069302-A7911991-22A8-484B-867D-1678A61BDA98Q37375539-11A8D9FC-3B29-443E-BE3E-E00FDC528151Q37438847-699C1698-479B-4BA3-9947-53BD0F4E4FB0Q37488800-106BF91C-FB13-4F05-9AF0-F0D6F4BDB846Q37596187-32E52EDA-0155-4B53-80B0-853DF90B1BE4Q37613264-11FEF12C-CD94-41F5-A643-C7E662A3E7FEQ37859419-74D1CB64-2C6B-48A8-982B-A4D3FDC9D584Q37884620-B7376718-14B0-4B9C-A464-DC6BA4EC63FDQ37978785-0926477C-2AD4-4D6A-82E1-63AB41063CAE
P2860
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Metformin in patients with non ...... randomized, controlled trial.
@en
Metformin in patients with non ...... randomized, controlled trial.
@nl
type
label
Metformin in patients with non ...... randomized, controlled trial.
@en
Metformin in patients with non ...... randomized, controlled trial.
@nl
prefLabel
Metformin in patients with non ...... randomized, controlled trial.
@en
Metformin in patients with non ...... randomized, controlled trial.
@nl
P2093
P2860
P1476
Metformin in patients with non ...... randomized, controlled trial.
@en
P2093
Else Marit Løberg
Gabriele Raschpichler
Heidi Beate Eggesbø
Hilde Løland von Volkmann
John Willy Haukeland
Kristian Bjøro
Kåre Birkeland
Terese Haaland
Zbigniew Konopski
P2860
P304
P356
10.1080/00365520902845268
P577
2009-01-01T00:00:00Z